Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
COYA-301 by Coya Therapeutics for Alzheimer's Disease: Likelihood of Approval
COYA-301 is under clinical development by Coya Therapeutics and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...
AL-001 by Alzamend Neuro for Alzheimer's Disease: Likelihood of Approval
AL-001 is under clinical development by Alzamend Neuro and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...
BIIB-113 by Biogen for Alzheimer's Disease: Likelihood of Approval
BIIB-113 is under clinical development by Biogen and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase I...
BMND-08 by Biomind Labs for Alzheimer's Disease: Likelihood of Approval
BMND-08 is under clinical development by Biomind Labs and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...